Affiliation:
1. Division of Infectious Diseases, Department of Internal Medicine Chang Gung Memorial Hospital, Linkou Medical Centre Taoyuan Taiwan
2. Department of Plant Pathology National Chung Hsing University Taichung Taiwan
3. Research Laboratory of Medical Mycology Chang Gung Memorial Hospital, Linkou Medical Centre Taoyuan Taiwan
4. School of Medicine Chang Gung University Taoyuan Taiwan
5. Department of Dermatology Chang Gung Memorial Hospital, Linkou Medical Centre Taoyuan Taiwan
Abstract
AbstractBackgroundScedosporiosis/lomentosporiosis is a globally emerging and crucial fungal infection. However, clinical data on Scedosporium/Lomentospora infections in Taiwan are scarce.ObjectivesThis study aimed to explore the clinical characteristics of Scedosporium/Lomentospora‐infected patients and evaluate the susceptibility of these isolates to antifungal agents.MethodsThe clinical features of Scedosporium/Lomentospora‐infected patients at a tertiary teaching hospital in Northern Taiwan between 2014 and 2021 were retrospectively reviewed; isolates from these patients were identified to species level for antifungal susceptibility testing.ResultsAmong 44 patients, 27 (61.4%) had scedosporiosis/lomentosporiosis, whereas 17 (38.6%) were colonised with Scedosporium/Lomentospora species. Scedosporium apiospermum was the main coloniser; scedosporiosis was primarily caused by S. boydii. Trauma history, steroid and immunosuppressant use were the most common risk factors for developing these infections. Among 27 patients with scedosporiosis/lomentosporiosis, one was lost to follow‐up and seven (7/26, 26.9%) died. Most patients with S. apiospermum infection have a history of trauma, leading to cutaneous, bone and ocular infections. Pulmonary, sinus and disseminated infections and mortality were frequently reported in patients with S. boydii infection. Voriconazole's minimum inhibitory concentration was low for S. boydii, S. apiospermum and S. aurantiacum. Caspofungin, micafungin and anidulafungin were active against S. boydii and S. apiospermum. A potentially novel Scedosporium species was identified in this study, with distinct clinical manifestations and antifungal susceptibility.ConclusionsAt our centre, S. boydii is the main causative species of scedosporiosis; voriconazole could be the first‐line treatment in Taiwan. Our study supports the importance of speciation, rather than only categorising these isolates into S. apiospermum species complex.
Subject
Infectious Diseases,Dermatology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献